Literature DB >> 26558400

Thyroid Hormone and Vascular Remodeling.

Toshihiro Ichiki1.   

Abstract

Both hyperthyroidism and hypothyroidism affect the cardiovascular system. Hypothyroidism is known to be associated with enhanced atherosclerosis and ischemic heart diseases. The accelerated atherosclerosis in the hypothyroid state has been traditionally ascribed to atherogenic lipid profile, diastolic hypertension, and impaired endothelial function. However, recent studies indicate that thyroid hormone has direct anti-atherosclerotic effects, such as production of nitric oxide and suppression of smooth muscle cell proliferation. These data suggest that thyroid hormone inhibits atherogenesis through direct effects on the vasculature as well as modification of risk factors for atherosclerosis. This review summarizes the basic and clinical studies on the role of thyroid hormone in vascular remodeling. The possible application of thyroid hormone mimetics to the therapy of hypercholesterolemia and atherosclerosis is also discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26558400     DOI: 10.5551/jat.32755

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  14 in total

1.  Severe Cerebral Vasospasm in Patients with Hyperthyroidism.

Authors:  Hyuk-Jin Oh; Seok-Mann Yoon; Jae-Sang Oh; Jai-Joon Shim; Hack-Gun Bae
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-12-31

Review 2.  Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.

Authors:  Hernando Vargas-Uricoechea; Anilza Bonelo-Perdomo
Journal:  Curr Heart Fail Rep       Date:  2017-02

Review 3.  Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

4.  Correlation between Thyroid Stimulating Hormone and Renal Function in Euthyroid Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Yuki Tanaka; Norihiro Furusyo; Yoshifumi Kato; Takatsugu Ueyama; Sho Yamasaki; Hiroaki Ikezaki; Masayuki Murata; Jun Hayashi
Journal:  J Atheroscler Thromb       Date:  2017-10-18       Impact factor: 4.928

5.  Dietary Selenium Intake and Subclinical Hypothyroidism: A Cross-Sectional Analysis of the ELSA-Brasil Study.

Authors:  Gustavo R G Andrade; Bartira Gorgulho; Paulo A Lotufo; Isabela M Bensenor; Dirce M Marchioni
Journal:  Nutrients       Date:  2018-05-30       Impact factor: 5.717

6.  TSH suppression aggravates arterial inflammation - an 18F-FDG PET study in thyroid carcinoma patients.

Authors:  Ellen Boswijk; Karin J C Sanders; Evie P M Broeders; Marlies de Ligt; Guy H E J Vijgen; Bas Havekes; Alma M A Mingels; Roel Wierts; Wouter D van Marken Lichtenbelt; Patrick Schrauwen; Felix M Mottaghy; Joachim E Wildberger; Jan Bucerius
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-11       Impact factor: 9.236

7.  A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves' Disease and Toxic Nodular Goiter.

Authors:  Dorota Walasik-Szemplińska; Grzegorz Kamiński; Małgorzata Mańczak; Joanna Widłak; Iwona Sudoł-Szopińska
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-17       Impact factor: 5.555

Review 8.  The Role of Thyroid Diseases and their Medications in Cardiovascular Disorders: A Review of the Literature.

Authors:  Negar Omidi; Mohammadrafie Khorgami; Farbod Z Tajrishi; Amirhosein Seyedhoseinpour; Parichehr Pasbakhsh
Journal:  Curr Cardiol Rev       Date:  2020

9.  Subclinical hypothyroidism is associated with lipid-rich plaques in patients with coronary artery disease as assessed by optical coherence tomography.

Authors:  Xiao-Qing Cai; Feng Tian; Tian-Wen Han; Dong-Kai Shan; Yang Liu; Wei-Jun Yin; Jing Jing; Qiang Xu; Yun-Dai Chen
Journal:  J Geriatr Cardiol       Date:  2018-08       Impact factor: 3.327

10.  Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.

Authors:  Yaoyao Guan; Adheesh Bhandari; Xiaohua Zhang; Ouchen Wang
Journal:  J Cell Mol Med       Date:  2019-09-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.